Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Melanocyte Lineage Factor miR-211 Promotes BRAFV600E Inhibitor Resistance

Journal of Investigative Dermatology(2021)10.1016/j.jid.2020.07.010Source: DataRank Database

The Melanocyte Lineage Factor miR-211 Promotes BRAFV600E Inhibitor Resistance is a research paper published in Journal of Investigative Dermatology (2021). On theSindex it has a DataRank of 0.241. It has been cited 4 times.

N/A

0.241DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.16)OA: greenTopics (40)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.241

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (2)

David E. Fisher ORCID,Stephen M. Ostrowski ORCID

Live enrichment

PubMed:33504438 PMC:PMC7850168 OpenAlex:https://openalex.org/W3123819273

National Institutes of Health

Grant: 1R01CA222871

National Institutes of Health

Grant: 5R01 AR043369-22

National Institutes of Health

Grant: R01AR072304

National Institutes of Health

Grant: 5P01 CA163222

NIAMS NIH HHS

Grant: R01 AR043369

NCI NIH HHS

Grant: R01 CA222871

NCI NIH HHS

Grant: P01 CA163222

Melanoma Research Alliance

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

FWCI

0.16

Citation Percentile

0.4%

Citation Trend

2022

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7850168

publisherhttps://api.elsevier.com/content/article/PII:S0022202X20319400?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022202X20319400?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jid.2020.07.010

Fields of Study

MicroRNA in disease regulationMelanoma and MAPK Pathwaysinterferon and immune responsesDrug Resistance, NeoplasmHumansMAP Kinase Signaling SystemMelanomaMicroRNAsMitogen-Activated Protein Kinase 7Protein Kinase InhibitorsProto-Oncogene Proteins B-rafTRPM Cation Channels

MeSH Terms

HumansMelanomaDrug Resistance, NeoplasmMAP Kinase Signaling SystemMicroRNAsProtein Kinase InhibitorsMitogen-Activated Protein Kinase 7Proto-Oncogene Proteins B-rafTRPM Cation Channels

Keywords

MelanomamicroRNACancer researchDownregulation and upregulationMicrophthalmia-associated transcription factorImmunotherapyTargeted therapyMelanocyteBiologyKinaseLineage (genetic)MedicineImmunologyCancerGeneCell biologyTranscription factorGeneticsImmune system

Sustainable Development Goals

SDG 0: Good health and well-being